In conclusion, using a well-established and accepted mouse model of PKR deletion, we find that the loss of PKR has no effect on the ability of cells to sense pro-inflammatory lipids in vitro, and does not alter the development of HFD-induced obesity or glucose intolerance in vivo. The gene discussed is EIF2AK2; the disease is obesity due to melanocortin 4 receptor deficiency.